NasdaqGS - Nasdaq Real Time Price • USD
Illumina, Inc. (ILMN)
As of 10:21 AM EDT. Market Open.
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 15 | 14 | 20 | 19 |
| Avg. Estimate | 0.04 | 0.15 | 0.89 | 2.44 |
| Low Estimate | -0.11 | 0 | 0.43 | 1.05 |
| High Estimate | 0.25 | 0.25 | 1.36 | 4.46 |
| Year Ago EPS | 0.08 | 0.32 | 0.86 | 0.89 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 14 | 13 | 19 | 19 |
| Avg. Estimate | 1.05B | 1.11B | 4.51B | 4.85B |
| Low Estimate | 1.03B | 1.06B | 4.35B | 4.42B |
| High Estimate | 1.06B | 1.15B | 4.68B | 5.13B |
| Year Ago Sales | 1.09B | 1.16B | 4.5B | 4.51B |
| Sales Growth (year/est) | -3.30% | -4.60% | 0.10% | 7.60% |
Earnings History
| CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | 0.02 | 0.02 | 0.12 | 0.02 |
| EPS Actual | 0.08 | 0.32 | 0.33 | 0.14 |
| Difference | 0.06 | 0.3 | 0.21 | 0.12 |
| Surprise % | 300.00% | 1,500.00% | 175.00% | 600.00% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0.04 | 0.15 | 0.89 | 2.44 |
| 7 Days Ago | 0.04 | 0.15 | 0.89 | 2.45 |
| 30 Days Ago | 0.04 | 0.15 | 0.89 | 2.46 |
| 60 Days Ago | 0.03 | 0.15 | 0.89 | 2.48 |
| 90 Days Ago | 0.06 | 0.17 | 0.82 | 2.38 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | 1 | 1 | 1 |
| Up Last 30 Days | 2 | 3 | 4 | 4 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | 1 | 2 | 3 |
Growth Estimates
| CURRENCY IN USD | ILMN | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -50.00% | -- | -- | 1.50% |
| Next Qtr. | -53.10% | -- | -- | 12.10% |
| Current Year | 3.50% | -- | -- | 4.40% |
| Next Year | 174.20% | -- | -- | 13.20% |
| Next 5 Years (per annum) | 22.90% | -- | -- | 10.97% |
| Past 5 Years (per annum) | -38.86% | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Maintains | Barclays: Underweight to Underweight | 4/10/2024 |
| Reiterates | Stephens & Co.: Overweight to Overweight | 4/10/2024 |
| Reiterates | RBC Capital: Outperform to Outperform | 4/9/2024 |
| Downgrade | OTR Global: Positive to Mixed | 3/20/2024 |
| Reiterates | Stephens & Co.: Overweight to Overweight | 2/14/2024 |
| Reiterates | RBC Capital: Outperform to Outperform | 2/9/2024 |
Related Tickers
EXAS Exact Sciences Corporation
59.91
+1.91%
TMO Thermo Fisher Scientific Inc.
573.04
+0.23%
GH Guardant Health, Inc.
17.30
+0.81%
DHR Danaher Corporation
245.65
-0.06%
TWST Twist Bioscience Corporation
31.21
+0.42%
NTRA Natera, Inc.
91.98
+0.77%
IDXX IDEXX Laboratories, Inc.
495.58
+1.30%
A Agilent Technologies, Inc.
137.51
+0.84%
DGX Quest Diagnostics Incorporated
135.71
+0.21%
WAT Waters Corporation
309.79
+0.47%